Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron

被引：0
|
作者：
Manuela Di Fusco
Xiaowu Sun
Mary M. Moran
Henriette Coetzer
Joann M. Zamparo
Mary B. Alvarez
Laura Puzniak
Ying P. Tabak
Joseph C. Cappelleri
机构：
[1] Pfizer Inc,Health Economics and Outcomes Research
[2] CVS Health,Field Medical Outcomes and Analytics
[3] Pfizer Inc,MDSCA Vaccines
[4] Pfizer Inc,Statistical Research and Data Science Center
[5] Pfizer Inc,undefined
[6] Pfizer Inc,undefined
来源：
Journal of Patient-Reported Outcomes | / 7卷
关键词：
COVID-19; SARS-CoV-2; COVID-19 symptoms; Long COVID; BNT162b2; Booster vaccine; HRQoL; WPAI;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron
    Di Fusco, Manuela
    Sun, Xiaowu
    Moran, Mary M.
    Coetzer, Henriette
    Zamparo, Joann M.
    Alvarez, Mary B.
    Puzniak, Laura
    Tabak, Ying P.
    Cappelleri, Joseph C.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
  • [2] BNT162b2 Vaccine Booster and Covid-19 Mortality
    Pilz, Stefan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 1000 - 1000
  • [3] Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
    Herishanu, Yair
    Avivi, Irit
    Levi, Shai
    Shefer, Gabi
    Bronstein, Yotam
    Moshiashvili, Miguel Morales
    Ziv, Tomer
    Sqarfo, Lydia
    Perry, Chava
    Ghia, Paolo
    BLOOD ADVANCES, 2022, 6 (01) : 148 - 151
  • [4] Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients
    Di Fusco, Manuela
    Sun, Xiaowu
    Moran, Mary M.
    Coetzer, Henriette
    Zamparo, Joann M.
    Puzniak, Laura
    Alvarez, Mary B.
    Tabak, Ying P.
    Cappelleri, Joseph C.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2022, 6 (01)
  • [5] Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients
    Manuela Di Fusco
    Xiaowu Sun
    Mary M. Moran
    Henriette Coetzer
    Joann M. Zamparo
    Laura Puzniak
    Mary B. Alvarez
    Ying P. Tabak
    Joseph C. Cappelleri
    Journal of Patient-Reported Outcomes, 6
  • [6] BNT162b2 Vaccine Booster and Mortality Due to Covid-19
    Arbel, Ronen
    Hammerman, Ariel
    Sergienko, Ruslan
    Friger, Michael
    Peretz, Alon
    Netzer, Doron
    Yaron, Shlomit
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26): : 2413 - 2420
  • [7] Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan
    Nagano, Mitsuhiro
    Kamei, Kazumasa
    Matsuda, Hiroyuki
    Takahashi, Chihiro
    Yang, Jingyan
    Wada, Koji
    Yonemoto, Naohiro
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 349 - 361
  • [8] Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
    Gouda, Wesam
    Albasri, Anwar
    Alsaqabi, Faisal
    Al Sabah, Humoud Y.
    Alkandari, Marwan
    Abdelnaby, Hassan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (05)
  • [9] Erythema multiforme following COVID-19 vaccination (BNT162b2)
    Wunderlich, K.
    Dirschka, T.
    HAUTARZT, 2022, 73 (01): : 68 - 70
  • [10] Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination
    Ikediobi, Ogechi
    Eichenfield, Dawn Z.
    Barrio, Victoria R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (05) : 823 - 824
12345